314 related articles for article (PubMed ID: 32648857)
1. Progress and current status of molecule-targeted therapy and drug resistance in gastric cancer.
Chen Z; Li Y; Tan B; Zhao Q; Fan L; Li F; Zhao X
Drugs Today (Barc); 2020 Jul; 56(7):469-482. PubMed ID: 32648857
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy for gastric cancer: Current status and future directions (Review).
Yuan DD; Zhu ZX; Zhang X; Liu J
Oncol Rep; 2016 Mar; 35(3):1245-54. PubMed ID: 26718131
[TBL] [Abstract][Full Text] [Related]
3. Advanced HER2-positive gastric cancer: current and future targeted therapies.
Pazo Cid RA; Antón A
Crit Rev Oncol Hematol; 2013 Mar; 85(3):350-62. PubMed ID: 23021388
[TBL] [Abstract][Full Text] [Related]
4. [Research status quo and progression in targeted therapy for advanced gastric cancer].
Feng R; Zhang X; Yang S
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1191-1196. PubMed ID: 27781258
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of different molecular targeted agents based on chemotherapy for gastric cancer patients treatment: a network meta-analysis.
Ren Z; Sun J; Sun X; Hou H; Li K; Ge Q
Oncotarget; 2017 Jul; 8(29):48253-48262. PubMed ID: 28477027
[TBL] [Abstract][Full Text] [Related]
6. Advances in targeted therapy for gastric cancer based on tumor driver genes.
Wu S; Xu P; Zhang F
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 53(1):73-83. PubMed ID: 38413217
[TBL] [Abstract][Full Text] [Related]
7. [Perspectives of the stomach cancer treatment: the introduction of molecular targeted therapy and the hope for cure].
Cheung DY; Kim JK
Korean J Gastroenterol; 2013 Mar; 61(3):117-27. PubMed ID: 23575230
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer.
Liu Y; Li C; Lu Y; Liu C; Yang W
Front Immunol; 2022; 13():1016817. PubMed ID: 36341377
[TBL] [Abstract][Full Text] [Related]
9. Recent advances and future trends in the targeted therapy of metastatic gastric cancer.
Al-Batran SE; Werner D
Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):555-69. PubMed ID: 24665840
[TBL] [Abstract][Full Text] [Related]
10. Clinical management of advanced gastric cancer: the role of new molecular drugs.
De Vita F; Di Martino N; Fabozzi A; Laterza MM; Ventriglia J; Savastano B; Petrillo A; Gambardella V; Sforza V; Marano L; Auricchio A; Galizia G; Ciardiello F; Orditura M
World J Gastroenterol; 2014 Oct; 20(40):14537-58. PubMed ID: 25356019
[TBL] [Abstract][Full Text] [Related]
11. Novel targeted agents for gastric cancer.
Liu L; Wu N; Li J
J Hematol Oncol; 2012 Jun; 5():31. PubMed ID: 22709792
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies in gastric cancer and future perspectives.
Yazici O; Sendur MA; Ozdemir N; Aksoy S
World J Gastroenterol; 2016 Jan; 22(2):471-89. PubMed ID: 26811601
[TBL] [Abstract][Full Text] [Related]
13. Molecular targeted therapy for the treatment of gastric cancer.
Xu W; Yang Z; Lu N
J Exp Clin Cancer Res; 2016 Jan; 35():1. PubMed ID: 26728266
[TBL] [Abstract][Full Text] [Related]
14. Efficacy prediction of targeted therapy for gastric cancer: The current status (Review).
Feng W; Zhu X
Mol Med Rep; 2018 Aug; 18(2):1238-1246. PubMed ID: 29901092
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy in gastric cancer.
Thiel A; Ristimäki A
APMIS; 2015 May; 123(5):365-72. PubMed ID: 25706252
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapies for gastric cancer: current status.
Yoong J; Michael M; Leong T
Drugs; 2011 Jul; 71(11):1367-84. PubMed ID: 21812503
[TBL] [Abstract][Full Text] [Related]
17. Research progress in targeted therapies for gastric cancer.
Ye M; Xiu LJ; Ji QQ; Zhang YC; Sun YW; Zhao Y; Wang D; Li YJ; Wang XW; Yue XQ; Sun DZ
Int J Clin Pharmacol Ther; 2022 Dec; 60(12):509-514. PubMed ID: 36197788
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging therapies in unresectable and recurrent gastric cancer.
Jou E; Rajdev L
World J Gastroenterol; 2016 May; 22(20):4812-23. PubMed ID: 27239108
[TBL] [Abstract][Full Text] [Related]
19. Gastric cancer: somatic genetics as a guide to therapy.
Zhang XY; Zhang PY
J Med Genet; 2017 May; 54(5):305-312. PubMed ID: 27609016
[TBL] [Abstract][Full Text] [Related]
20. Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer.
Meric-Bernstam F; Johnson AM; Dumbrava EEI; Raghav K; Balaji K; Bhatt M; Murthy RK; Rodon J; Piha-Paul SA
Clin Cancer Res; 2019 Apr; 25(7):2033-2041. PubMed ID: 30442682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
